Literature DB >> 11820317

Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles.

P Gregorevic1, G S Lynch, D A Williams.   

Abstract

In skeletal muscle the activity of the enzymatic antioxidants superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) is regulated in response to generation of reactive oxygen species (ROS). Increased activity of these enzymes is observed after repeated bouts of aerobic exercise, a potent stimulus for intracellular ROS production. Hyperbaric oxygen (HBO) inhalation also stimulates intracellular ROS production although the effects of HBO on skeletal muscle SOD, GPx and CAT activity have not been studied. We tested the hypothesis that SOD, GPx and CAT activity is modulated in skeletal muscles in response to acute and repeated HBO administration. In adult male rats acute HBO inhalation (60 mm at 3 atmospheres absolute) reduced catalase activity by approximately 51% in slow-twitch soleus muscles. Additionally, repeated HBO inhalation (twice daily for 28 days) increased Mn2+-superoxide dismutase activity by approximately 241% in fast-twitch extensor digitorum longus muscles. We conclude that both acute and repeated HBO inhalation can alter enzymatic antioxidant activity in skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11820317     DOI: 10.1007/s004210100503

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  21 in total

1.  Susceptibility of two strains of mice to the infection with Schistosoma mansoni: parasitological and biochemical studies.

Authors:  Saad M Bin Dajem; Osama M S Mostafa; Fahmy G El-Said
Journal:  Parasitol Res       Date:  2008-07-12       Impact factor: 2.289

Review 2.  Oxidative stress is fundamental to hyperbaric oxygen therapy.

Authors:  Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

Review 3.  Hyperbaric oxygen: its mechanisms and efficacy.

Authors:  Stephen R Thom
Journal:  Plast Reconstr Surg       Date:  2011-01       Impact factor: 4.730

4.  The effect of hyperbaric oxygenation therapy on myocardial function.

Authors:  Marina Leitman; Shai Efrati; Shmuel Fuchs; Amir Hadanny; Zvi Vered
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-17       Impact factor: 2.357

5.  Biochemical assessment of oxidative status versus liver enzymes in patients with chronic fascioliasis.

Authors:  Hanan H Kamel; Rania M Sarhan; Ghada A Saad
Journal:  J Parasit Dis       Date:  2014-02-05

6.  The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following in vitro stress in human monocytes.

Authors:  Rebecca V Vince; Adrian W Midgley; Gerard Laden; Leigh A Madden
Journal:  Cell Stress Chaperones       Date:  2010-12-05       Impact factor: 3.667

7.  The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage.

Authors:  Mustafa Edremitlioğlu; Dilek Kiliç; Sükrü Oter; Uçler Kisa; Ahmet Korkmaz; Omer Coşkun; Orhan Bedir
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats.

Authors:  Yoshiteru Soejima; Qin Hu; Paul R Krafft; Mutsumi Fujii; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2013-03-26       Impact factor: 5.330

9.  Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss.

Authors:  Takeyuki Fujimura; Hideaki Suzuki; Teruo Shiomori; Tsuyoshi Udaka; Takanori Mori
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-06       Impact factor: 2.503

10.  Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney.

Authors:  Irit Rubinstein; Zaid Abassi; Felix Milman; Elena Ovcharenko; Rymond Coleman; Joseph Winaver; Ori S Better
Journal:  Nephrol Dial Transplant       Date:  2008-09-17       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.